大幸薬品の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/07/21 | 1,147 | 1,188 | 1,145 | 1,153 | +8 | +0.7% | 51,200 |
| 2010/07/20 | 1,175 | 1,175 | 1,101 | 1,145 | -42 | -3.5% | 111,300 |
| 2010/07/16 | 1,208 | 1,219 | 1,181 | 1,187 | -53 | -4.3% | 71,300 |
| 2010/07/15 | 1,290 | 1,290 | 1,218 | 1,240 | -63 | -4.8% | 104,200 |
| 2010/07/14 | 1,319 | 1,319 | 1,270 | 1,303 | -23 | -1.7% | 59,200 |
| 2010/07/13 | 1,363 | 1,377 | 1,325 | 1,326 | -40 | -2.9% | 38,100 |
| 2010/07/12 | 1,365 | 1,370 | 1,360 | 1,366 | -4 | -0.3% | 21,100 |
| 2010/07/09 | 1,404 | 1,404 | 1,370 | 1,370 | -4 | -0.3% | 17,100 |
| 2010/07/08 | 1,376 | 1,388 | 1,370 | 1,374 | +3 | +0.2% | 22,200 |
| 2010/07/07 | 1,410 | 1,412 | 1,360 | 1,371 | -48 | -3.4% | 59,500 |
| 2010/07/06 | 1,413 | 1,419 | 1,404 | 1,419 | -3 | -0.2% | 34,700 |
| 2010/07/05 | 1,412 | 1,428 | 1,411 | 1,422 | +1 | +0.1% | 14,400 |
| 2010/07/02 | 1,421 | 1,437 | 1,410 | 1,421 | -8 | -0.6% | 33,600 |
| 2010/07/01 | 1,430 | 1,441 | 1,420 | 1,429 | -11 | -0.8% | 36,700 |
| 2010/06/30 | 1,440 | 1,448 | 1,430 | 1,440 | -30 | -2% | 45,300 |
| 2010/06/29 | 1,459 | 1,470 | 1,451 | 1,470 | +5 | +0.3% | 44,000 |
| 2010/06/28 | 1,480 | 1,480 | 1,453 | 1,465 | -3 | -0.2% | 36,000 |
| 2010/06/25 | 1,465 | 1,482 | 1,461 | 1,468 | -5 | -0.3% | 38,200 |
| 2010/06/24 | 1,478 | 1,480 | 1,465 | 1,473 | -11 | -0.7% | 41,100 |
| 2010/06/23 | 1,461 | 1,493 | 1,461 | 1,484 | +9 | +0.6% | 94,300 |
| 2010/06/22 | 1,461 | 1,475 | 1,461 | 1,475 | +4 | +0.3% | 25,800 |
| 2010/06/21 | 1,461 | 1,474 | 1,459 | 1,471 | +10 | +0.7% | 26,100 |
| 2010/06/18 | 1,464 | 1,469 | 1,459 | 1,461 | -13 | -0.9% | 52,500 |
| 2010/06/17 | 1,475 | 1,500 | 1,457 | 1,474 | +1 | +0.1% | 72,100 |
| 2010/06/16 | 1,478 | 1,480 | 1,470 | 1,473 | -3 | -0.2% | 38,100 |
| 2010/06/15 | 1,480 | 1,480 | 1,467 | 1,476 | ±0 | ±0% | 44,000 |
| 2010/06/14 | 1,476 | 1,502 | 1,474 | 1,476 | -4 | -0.3% | 41,900 |
| 2010/06/11 | 1,480 | 1,494 | 1,470 | 1,480 | -9 | -0.6% | 95,100 |
| 2010/06/10 | 1,484 | 1,505 | 1,484 | 1,489 | +4 | +0.3% | 22,300 |
| 2010/06/09 | 1,484 | 1,508 | 1,482 | 1,485 | -36 | -2.4% | 57,000 |
| 2010/06/08 | 1,475 | 1,528 | 1,475 | 1,521 | +5 | +0.3% | 61,200 |
| 2010/06/07 | 1,524 | 1,544 | 1,503 | 1,516 | -64 | -4.1% | 48,800 |
| 2010/06/04 | 1,580 | 1,590 | 1,572 | 1,580 | -9 | -0.6% | 23,800 |
| 2010/06/03 | 1,578 | 1,599 | 1,578 | 1,589 | ±0 | ±0% | 35,300 |
| 2010/06/02 | 1,589 | 1,600 | 1,574 | 1,589 | -19 | -1.2% | 44,700 |
| 2010/06/01 | 1,670 | 1,680 | 1,517 | 1,608 | -50 | -3% | 137,600 |
| 2010/05/31 | 1,630 | 1,670 | 1,610 | 1,658 | +58 | +3.6% | 176,600 |
| 2010/05/28 | 1,530 | 1,650 | 1,530 | 1,600 | +77 | +5.1% | 378,400 |
| 2010/05/27 | 1,520 | 1,545 | 1,496 | 1,523 | -27 | -1.7% | 78,900 |
| 2010/05/26 | 1,494 | 1,550 | 1,450 | 1,550 | +63 | +4.2% | 90,800 |
| 2010/05/25 | 1,500 | 1,555 | 1,480 | 1,487 | -6 | -0.4% | 123,100 |
| 2010/05/24 | 1,437 | 1,498 | 1,437 | 1,493 | +36 | +2.5% | 49,300 |
| 2010/05/21 | 1,434 | 1,473 | 1,430 | 1,457 | -36 | -2.4% | 64,800 |
| 2010/05/20 | 1,525 | 1,559 | 1,493 | 1,493 | -32 | -2.1% | 123,900 |
| 2010/05/19 | 1,456 | 1,539 | 1,456 | 1,525 | +71 | +4.9% | 109,100 |
| 2010/05/18 | 1,451 | 1,490 | 1,451 | 1,454 | +1 | +0.1% | 109,500 |
| 2010/05/17 | 1,469 | 1,479 | 1,423 | 1,453 | -45 | -3% | 164,800 |
| 2010/05/14 | 1,488 | 1,570 | 1,480 | 1,498 | +11 | +0.7% | 228,500 |
| 2010/05/13 | 1,500 | 1,509 | 1,484 | 1,487 | -8 | -0.5% | 71,400 |
| 2010/05/12 | 1,491 | 1,510 | 1,489 | 1,495 | -8 | -0.5% | 50,500 |
3651～
3700
件表示中 / 3978件
類似銘柄と比較する
現在ご覧いただいている「大幸薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大幸薬品 | 36,700円 | +0.1% | -70.9% | 0.00% | 61.37倍 | 2.31倍 |
|
止瀉薬「正露丸」で有名な大衆薬中堅。オーナー経営色。感染管理「クレベリン」事業は再構築中 |
| ステムリム | 32,600円 | - | - | 0.00% | - | 3.00倍 |
|
大阪大学発バイオベンチャー。損傷細胞の活性化物質を動員、再生を促す「再生誘導医薬」を開発 |
| 扶桑薬 | 210,200円 | +1.6% | -12.7% | 4.28% | 7.81倍 | 0.54倍 |
|
人工腎臓用透析剤・補液が主軸の製薬中堅、透析剤は国内シェア５割。後発薬や製造受託も展開 |
| ＣＡＮＢＡＳ | 96,600円 | - | - | 0.00% | - | 6.18倍 |
|
抗がん剤開発に特化した創薬ベンチャー。主力の膵臓がん治療薬候補は自社開発。導出も模索 |
| キッズバイオ | 37,000円 | - | - | 0.00% | - | 13.17倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
市場注目の銘柄
チャート関連のコラム
